TY  - GEN
AU  - Redondo, Andres
AU  - Ramos Vazquez, Manuel
AU  - Manso, Luis
AU  - Gil Gil, Miguel J
AU  - Garau Llinas, Isabel
AU  - Garcia-Garre, Elisa
AU  - Rodriguez, Cesar A
AU  - Ignacio Chacon, Jose
AU  - Lopez-Vivanco, Guillermo
PY  - 2018
DO  - 10.2147/OTT.S170303
SN  - 1178-6930
UR  - https://hdl.handle.net/20.500.12105/22624
AB  - Background: Randomized controlled trials of the first-line combination of bevacizumab and chemotherapy in patients with metastatic breast cancer (MBC) have shown improvements in tumor response and progression-free survival (PFS). Objective: The aim of...
LA  - eng
PB  - Dove Medical Press
KW  - Bevacizumab
KW  - Metastatic breast cancer
KW  - Real-world
KW  - Maintenance hormonal therapy
KW  - Taxane
TI  - Long-term response to first-line bevacizumab-based therapy in patients with metastatic breast cancer: results of the observational LORENA study
TY  - research article
ER  -